SRPT Sarepta Therapeutics Inc
18,439
$131.82
$0.48
(0.36%)
| Watchers | 18,439 |
| 52-Wk Low | $55.25 |
| 52-Wk High | $159.89 |
| Market Cap | $12.51B |
| Volume | 735,538.00 |
| 52-Wk High | $159.89 |
| 52-Wk Low | $55.25 |
Gene Therapy Pioneer Jerry R. Mendell, M.D., Named to Inaugural TIME100 Health List of the 100 Most Influential People in Global HealthBusiness Wire • 7 days ago
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that TIME named renown neuromuscular researcher, physician and gene therapy...
Share to Feed
Latest Ratings for SRPT
DateFirmActionFromTo Mar 2022Morgan StanleyMaintainsEqual-Weight Mar 2022RBC CapitalMaintainsOutperform Feb 2022Morgan StanleyMaintainsEqual-Weight
View More Analyst...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported financial results for the first quarter 2024. We are pleased to announce another...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on April 30, 2024 that were previously approved by the Compensation...
Designed to provide broad exposure to the Small Cap Blend segment of the US equity market, the iShares Morningstar Small-Cap ETF (ISCB) is a passively managed exchange traded fund launched on...
The biotech industry can be attractive for several reasons. Many leading biotechs develop innovative, life-saving therapies, a business that will only be phased out once we find an all-purpose cure...
Sarepta Therapeutics (NASDAQ:SRPT - Get Free Report) and PTC Therapeutics (NASDAQ:PTCT - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on March 29, 2024 that were previously approved by the Compensation...
It has been about a month since the last earnings report for Sarepta Therapeutics (SRPT). Shares have added about 1.2% in that time frame, underperforming the S&P 500.Will the recent positive trend...
This is a Bullish indicator signaling SRPT's price could rise from here. Traders may explore going long the stock or buying call options...